Fusion Pharmaceuticals Inc (FUSN)
21.45
-0.04
(-0.19%)
USD |
NASDAQ |
May 03, 16:00
21.44
-0.02
(-0.07%)
After-Hours: 20:00
Fusion Pharmaceuticals Shares Outstanding: 84.69M for March 15, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
March 15, 2024 | 84.69M |
March 11, 2024 | 84.69M |
December 31, 2023 | 79.70M |
October 27, 2023 | 72.41M |
September 30, 2023 | 69.15M |
July 28, 2023 | 69.00M |
June 30, 2023 | 68.99M |
June 14, 2023 | 68.87M |
May 15, 2023 | 67.98M |
May 02, 2023 | 63.85M |
April 18, 2023 | 63.20M |
March 31, 2023 | 63.20M |
March 06, 2023 | 63.20M |
February 17, 2023 | 62.72M |
February 16, 2023 | 62.45M |
December 31, 2022 | 44.81M |
October 28, 2022 | 44.76M |
September 30, 2022 | 44.76M |
July 29, 2022 | 43.39M |
June 30, 2022 | 43.38M |
April 29, 2022 | 43.34M |
April 18, 2022 | 43.34M |
Date | Value |
---|---|
April 01, 2022 | 43.33M |
March 31, 2022 | 43.33M |
March 07, 2022 | 43.33M |
December 31, 2021 | 43.07M |
November 02, 2021 | 43.07M |
September 30, 2021 | 43.07M |
August 03, 2021 | 43.02M |
July 01, 2021 | 42.93M |
June 30, 2021 | 42.62M |
May 03, 2021 | 42.46M |
April 09, 2021 | 42.45M |
April 01, 2021 | 42.45M |
March 31, 2021 | 41.85M |
March 15, 2021 | 41.85M |
December 31, 2020 | 41.73M |
November 03, 2020 | 41.73M |
September 30, 2020 | 41.70M |
August 04, 2020 | 41.66M |
June 30, 2020 | 41.66M |
June 26, 2020 | 41.66M |
June 22, 2020 | 41.66M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
41.66M
Minimum
Jun 22 2020
84.69M
Maximum
Mar 11 2024
52.15M
Average
43.34M
Median
Apr 18 2022
Shares Outstanding Benchmarks
AstraZeneca PLC | 3.100B |
Landos Biopharma Inc | 3.117M |
Perspective Therapeutics Inc | 586.92M |
Acasti Pharma Inc | 9.399M |
Aurinia Pharmaceuticals Inc | 143.02M |